This 30-minute session expands on the STS Roadmap to Mobile Lung Cancer Screenings and examines the intricacies of mobile cancer screening units and how they operate. The event is open to all interested in creating or expanding a mobile cancer screening initiative at their institution.
Moderator
Elliot L. Servais, MD Lahey Hospital & Medical Center Burlington, MA
This webinar will review significant lung infections such as costicercosis, tuberculosis and hidatidosis. Our expert panel with US and LATAM speakers will go over controversial topics on these 3 diseases, including state-of-the-art management and different options in surgical approach.
This webinar will explore the evolving landscape of neoadjuvant and adjuvant treatment for lung cancer. Oncologists and surgeon experts will highlight the latest data, including immunotherapy and targeted mutation strategies from ASCO and WCLC, and examine how these advances impact surgical decision-making, techniques, and patient outcomes. A live discussion will address key controversies, including the role of radiation and adjuvant therapy choices.
Supported by AstraZeneca
Moderator
Joseph Shrager, MD Stanford University Palo Alto, CA
The premier annual event in cardiothoracic surgery, unveiling never-before-seen science, techniques, and technology, and creating a forum to build lasting connections with colleagues.
Learn about the different facets of STS advocacy, what it can do for you, and how you can make a lasting impact on the cardiothoracic surgery specialty. Presenters share how STS advocacy intersects with everyday aspects of members' surgical practices, as well as their personal, professional, and institutional priorities from quality improvement to coding and reimbursement.
Recently the American College of Surgeons Commission on Cancer (CoC) updated its Quality of Care Measures for CoC-accredited cancer programs to treat patients. In this episode of the STS Webinar Series, an expert panel discusses the rationale behind the revised CoC Standard 5.8, how implementation of the new measures can optimize surgical processes and improve patient outcomes—and how to react when your institution’s performance reports indicate you could do more.
The Congenital Heart Surgery Database (CHSD) continues to undergo improvements to enhance quality of care for patients. In this webinar for CHSD participants, the panel discusses the forthcoming upgrade to version 6.22 and implementation of new STAT scores. The webinar also includes a review of the brand-new Adults with Congenital Heart Disease (ACHD) component. The surgeon leaders discuss the goals for the ACHD component, how data will be captured, and what the future holds in terms of risk assessment for this rapidly growing population.
